We are delighted to announce the significant expansion of F1000 Research’s Advisory Panel to include almost 100 world leading scientists and clinicians across biology and medicine. This group will form our Editorial Advisory Group and provide us with a solid sounding board for our ideas as we refine our plans. Our existing Advisory Panel members…
The first in a series of awards marking the achievements of our Faculty Members.
We are excited to announce that a Faculty of 1000 app is now available to Science Direct subscribers within Elsevier’s SciVerse Applications Gallery, allowing researchers, clinicians and students to easily tap into the collective knowledge of our 10,000 expert Faculty Members while browsing articles on ScienceDirect and Scopus. Once a SciVerse user adds the app,…
I promised in my last post to follow up on some recurring themes in many of the discussions that have been ongoing around the plans for F1000 Research. One of the other major issues relates to the idea that our plans will increase dissemination of poor quality science and the subsequent impact of this. Will…
Caltech researchers pioneer a new approach to HIV vaccination in mice via ‘vectored immunoprophylaxis’ (VIP).
John Couchman on why syndecans are emerging as important players in the world of cell adhesion.
First, a big thank you for all the supportive comments on Twitter and in the blogosphere to our plans at F1000 Research. We are under no illusion this is going to be a tough project and need all the feedback you can offer! Unsurprisingly, the greatest concerns have been around the idea of immediate publication…
Jan Lammerding on the importance of nuclear envelope proteins.
A proposed ban on organ donation after cardiocirculatory death.
Stefan Linder on actin regulatory mechanisms and intracellular trafficking along microtubules.
